Título
Pedro J. Prada, María Ferri, Juan Cardenal, Ana García Blanco, Javier Anchuelo, Andrea Kannemann, Iván Díaz de Cerio, Andrés Vázquez, Maite Pacheco, Ignacio Raba, Samuel Ruiz
High-Dose-Rate Interstitial Brachytherapy as Monotherapy in one fraction of 20.5 Gy for the treatment of localized prostate cancer: Toxicity and 6-years biochemical results. Brachytherapy 2018; 17:845-851. Purpose: To evaluate acute and late genitourinary toxicity, the gastrointestinal toxicity, and the long-term biochemical control after high-dose-rate (HDR) monotherapy in one fraction (20.5 Gy).